Clinical trial
Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis
NCT03113721
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedAssessment of Heparin Binding Protein for the Prediction of Severe Sepsis
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Axis Shield Diagnostics Ltdlead sponsor
Drexel Universitycollaborator
York Hospitalscollaborator
Vanderbilt University Medical Centercollaborator
Baylor College of Medicinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03113721 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.